health

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

SINGAPORE, Sept. 25, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester...

Basecamp Research raises $140M to advance AI-designed therapeutics

LONDON and BOSTON, Sept. 23, 2026 /PRNewswire/ -- Basecamp Research, a frontier AI company developing AI-designed medicines, today announced a $140M Series C financing to train a new generation of EDEN models and advance a pipeline of AI-designed therapeutics towards clinical development.Basecamp's ambition is to develop cures for diseases that remain incurable by designing medicines that reprogram the body to repair itself. The company...

HKSH Medical Group and United Imaging Mark Launch of Hong Kong’s First Long-Axial PET/CT

HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging clinical applications and research in Hong Kong. As one of Hong Kong's leading private hospitals, HKSH...

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

MINNEAPOLIS and DÜSSELDORF, Germany, Sept. 22, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the opening of its new Customer Experience Center in Düsseldorf, Germany, a flagship facility designed to bring European customers closer to Bio-Techne's latest innovations and scientific expertise.

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that Sovargen Co., Ltd., a biotechnology company specializing in central nervous system (CNS) diseases that has exclusively licensed paxalisib from Kazia for the development and...

Hylenr Completes Phase 1 LCF Reactor Validation at Texas A&M University

HYDERABAD, India, Sept. 22, 2026 /PRNewswire/ -- Hyderabad based Deeptech company Hylenr today announced the completion of Phase 1 of an independent validation study of Lattice Confinement Fusion (LCF), conducted at Texas A&M University, marking an important step in the company's efforts to independently evaluate its lattice-based energy technology and advance its roadmap toward commercialization.

Merry Life Biomedical Advances Global Phase 2 Trial of TML-6, Exploring Cellular Protein Clearance in Early Alzheimer’s Disease

TAIPEI, Sept. 22, 2026 /PRNewswire/ -- Merry Life Biomedical today announced the advancement of TML-6, a Taiwan-developed investigational oral therapy for early Alzheimer's disease, into a global Phase 2 study spanning Taiwan, Sweden, and the United States.The study brings together 20 clinical sites, including nine medical centers in Taiwan, seven sites in Sweden, and four centers in the United States. It will evaluate TML-6 in approximately...

Health hazard: doctors say it’s time to run out of gas

Australia should stop approving new gas projects and phase out use of the fossil fuel to protect public health as well as the environment, a report says.

Stay up to date

On all things Queensland

Please wait...

Thank you for sign up!